Delanzomib (CEP-18770)
Delanzomib (CEP-18770) is an orally active inhibitor of the chymotrypsin-like activity of proteasome with IC50 of 3.8 nM, with only marginal inhibition of the tryptic and peptidylglutamyl activities of the proteosome. Phase 1/2.
Supplier | Selleck Chemicals |
---|---|
Product # | S1157 |
Sku # | S1157-50mg |
Pricing | 50mg, $997.00 |